Specific S100 Proteins Bind Tumor Necrosis Factor and Inhibit Its Activity

Tumor necrosis factor (TNF) inhibitors (anti-TNFs) represent a cornerstone of the treatment of various immune-mediated inflammatory diseases and are among the most commercially successful therapeutic agents. Knowledge of TNF binding partners is critical for identification of the factors able to affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazakov, Alexey S., Zemskova, Marina Y., Rystsov, Gleb K., Vologzhannikova, Alisa A., Deryusheva, Evgenia I., Rastrygina, Victoria A., Sokolov, Andrey S., Permyakova, Maria E., Litus, Ekaterina A., Uversky, Vladimir N., Permyakov, Eugene A., Permyakov, Sergei E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783754/
https://www.ncbi.nlm.nih.gov/pubmed/36555597
http://dx.doi.org/10.3390/ijms232415956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783754/
https://www.ncbi.nlm.nih.gov/pubmed/36555597
http://dx.doi.org/10.3390/ijms232415956

Ejemplares similares